secwatch.observer — SEC 8-K summary
======================================

Issuer:     Armata Pharmaceuticals, Inc. (ARMP)
CIK:        0000921114
Form:       8-K
Filed at:   2025-12-01T23:59:59+00:00
Accession:  0001104659-25-117387
Event type: other_material
Sentiment:  neutral
Materiality: 0.60
Item codes: 1.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Armata enters ATM offering agreement for up to $100M of common stock
--------------------------------------------------------------------

- Entered Capital on Demand Sales Agreement with JonesTrading for at-the-market offering of common stock up to $100M.
- JonesTrading will earn commission of up to 3.0% of gross proceeds; sales may be made on NYSE American.
- Company not obligated to sell; Jones not obligated to buy; program entirely at Company's discretion.
- Offered under existing S-3 registration statement (File No. 333-289585) and prospectus supplement dated Dec 1, 2025.
- Agreement contains customary representations, warranties, and indemnification; either party may terminate on three days' notice.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/921114/000110465925117387/0001104659-25-117387-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/921114/000110465925117387/tm2532031d2_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-25-117387

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer